Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults: The Third National Health and Nutrition Examination Survey (NHANES III)

Annals of Epidemiology

Volumn 9, Issue 6, 1999, Pages 358-365

  Simon, Joel A ^a,b   Hudes, Esther S ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Ascorbic acid; Coronary disease; Stroke

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; DIETARY INTAKE; EDUCATION; ETHNIC GROUP; FEMALE; FITNESS; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUTRITION; PRIORITY JOURNAL; RISK; RISK BENEFIT ANALYSIS; SMOKING; STATISTICAL ANALYSIS; STROKE; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANGINA PECTORIS; ASCORBIC ACID; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 0033179142     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(99)00008-3     Document Type: Article

References (50)

1. Frei B., Stocker R., England L., Ames B.N. Ascorbate. The most effective antioxidant in human plasma Adv Exp Med Biol. 264:1990;155-163.
2. Simon J.A. Vitamin C and cardiovascular disease. A review J Am Coll Nutr. 11:1992;107-125.
3. Jacob R.A., Skala J.H., Omaye T. Biochemical indices of human vitamin C status. Am J Clin Nutr. 46:1987;818-826.
4. Gey K.F. Optimum plasma levels of antioxidant micronutrients. Bibl Nutr Dieta. 51:1994;84-99.
5. Simon J.A., Hudes E.S., Browner W.S. Serum ascorbic acid and cardiovascular disease prevalence in US adults. Epidemiology. 9:1998;316-321.
6. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. National Center for Health Statistics. Vital Health Stat. 1(32) 1994.
7. Rose G.A., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular Survey Methods. 2nd ed:1982;World Health Organization, Geneva.
8. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the Third Health and Nutrition Examination Survey (NHANES III), 1988-1994. US Department of Health and Human Services, PHS, Centers for Disease Control and Prevention, Center for Environmental Health, Atlanta, GA and National Center for Health Statistics, Hyattsville, MD; 1996.
9. Jacob R.A. Assessment of human vitamin C status. J Nutr. 120:1990;1480-1485.
10. Sauberlich H.E., Kretsch M.J., Taylor P.C., Johnson H.L., Skala J.H. Ascorbic acid and erythorbic acid metabolism in nonpregnant women. Am J Clin Nutr. 50:1989;1039-1049.
11. Stata Corp 1996. Stata Statistical Software: Release 5.0; College Station, TX: Stata Corp; 1996.
12. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 74:1979;829-836.
13. Simon J.A., Grady D., Snabes M.C., Fong J., Hunninghake D.B. Ascorbic acid supplement use and the prevalence of gallbladder disease. J Clin Epidemiol. 51:1998;257-265.
14. Ginter E., Zloch Z., Ondreicka R. Influence of vitamin C status on ethanol metabolism in guinea-pigs. Physiol Res. 47:1998;137-141.
15. Krasner N., Dow J., Moore M.R., Goldberg A. Ascorbic-acid saturation and ethanol metabolism. Lancet. 2:1974;693-695.
16. Beetens J.R., Herman A.G. Vitamin C increases the formation of prostacyclin by aortic rings from various species and neutralizes the inhibitory effect of 15-hydroxy-arachidonic acid. Br J Pharm. 80:1983;249-254.
17. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 97:1996;22-28.
18. Jialal I., Vega G.L., Grundy S.M. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis. 82:1990;185-191.
19. Harats D., Ben-Naim M., Dabach Y., Hollander G., Havivi E., Stein O., Stein Y. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis. 85:1990;47-54.
20. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr. 54:1991;1113S-1118S.
21. Frei B., Forte T.M., Ames B.N., Cross C.E. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J. 277:1991;133-138.
22. Retsky K.L., Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta. 1257:1995;279-287.
23. Gey K.F. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta. 37:1986;53-91.
24. Steinberg D. Antioxidants and atherosclerosis. A current assessment Circulation. 84:1991;1420-1425.
25. Simon J.A., Schreiber G.B., Crawford P.B., Frederick M.M., Sabry Z.I. Dietary vitamin C and serum lipids in black and white girls. Epidemiology. 4:1993;537-542.
26. Jacques P.F., Sulsky S.I., Perrone G.A., Schaefer E.J. Ascorbic acid and plasma lipids. Epidemiology. 5:1994;19-26.
27. 2 cholesterol. Am J Clin Nutr. 60:1994;100-105.
28. 1 in washed human platelets and prostacyclin in rat aortic rings. Prostaglan Leukotr Med. 18:1985;227-233.
29. Toivanen J.L. Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro. Prostaglan Leukotr Med. 26:1987;265-280.
30. Lefer A.M. Prostacyclin, high density lipoproteins, and myocardial ischemia. Circulation. 81:1990;2013-2015.
31. Lehr H.-A., Frei B., Olofsson A.M., Carew T.E., Arfors K.-E. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not vitamin E. Circulation. 91:1995;1525-1532.
32. Knox E.G. Ischemic-heart-disease mortality and dietary intake of calcium. Lancet. 1:1973;1465-1467.
33. Ramirez J., Flowers N.C. Leukocyte ascorbic acid and its relationship to coronary artery disease in man. Am J Clin Nutr. 33:1980;2079-2087.
34. Gey K.F., Moser U.K., Jordan P., Stähelin H.B., Eichholzer M., Lüdin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants. An epidemiologic update with special attention to carotene and vitamin C Am J Clin Nutr. 57(Suppl 5):1993;787S-797S.
35. Gey K.F., Stähelin H.B., Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke. Basel Prospective Study Clin Investig. 71:1993;3-6.
36. Riemersma R.A., Wood D.A., Macintyre C.C.A., Elton R.A., Gey K.F., Oliver M.F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 1:1991;1-5.
37. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 328:1993;1444-1449.
38. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med. 328:1993;1450-1456.
39. Knekt P., Reunanen A., Järvinen R., Seppänen R., Heliövaara M., Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 139:1994;1180-1189.
40. Nyyssönen K., Parviainen M.T., Salonen R., Tuomilehto J., Salonen J.T. Vitamin C deficiency and risk of myocardial infarction. Prospective population study of men from eastern Finland BMJ. 314:1997;634-638.
41. Enstrom J.E., Kanim L.E., Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 3:1992;194-202.
42. Jha P., Flather M., Lonn E., Farouh M., Yusef S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data Ann Intern Med. 123:1995;860-872.
43. Gale C.R., Martyn C.N., Winter P.D., Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J. 310:1995;1563-1566.
44. Barer D., Leibowitz R., Ebrahim S., Pengally D., Neale R. Vitamin C status and other nutritional indices in patients with stroke and other acute illnesses. A case-control study J Clin Epidemiol. 42:1989;625-631.
45. Keli S.O., Hertog M.G.L., Feskens E.J.M., Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med. 154:1996;637-642.
46. Jacques P.F., Sulsky S.I., Sadowski J.A., Phillips J.C.C., Rush D., Willett W.C. Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr. 57:1993;182-189.
47. Jacob R.A., Pianalto F.S., Agee R.E. Cellular ascorbate depletion in healthy men. J Nutr. 122:1992;1111-1118.
48. Hume R., Weyers E., Rowan T., Reid D.S., Hillis W.S. Leucocyte ascorbic acid levels after myocardial infarction. Br Heart J. 34:1972;238-243.
49. Machtey I., Syrkis I., Fried M. Studies of blood ascorbic acid levels in acute myocardial infarction. Clin Chim Acta. 62:1975;149-151.
50. Labadarios D., Brink P.A., Weich H.F.H., Visser L., Louw M.E.J., Shephard G.S., Van Stuijvenberg M.E. Plasma vitamin A, E, C and B6 levels in myocardial infarction. S Afr Med J. 71:1987;561-563.